Delgocitinib Cream Produces Robust Response to Eczema

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped treatment stayed clear or nearly clear for 8 weeks.
Medscape Medical News

source https://www.medscape.com/viewarticle/analysis-takes-deep-dive-robust-response-delgocitinib-2025a10005qv?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost